SHANXI KANGBAO · COMPANY INFORMATION
Company documents & public records
Check dated company identity, licence and biological-product release references, with their scope and limits for research-catalog materials.
These references make the company presentation auditable. Each entry identifies what was found and the limit of the conclusion. Public company information remains separate from the documents for a research-catalog lot.
Company identity and licence reference
| Field | Recorded information | Source and scope |
|---|---|---|
| Chinese company name | 山西康宝生物制品股份有限公司 | Historical official manufacturing-licence archive |
| English presentation name | Shanxi Kangbao Biological Product Co., Ltd. | English name used in the supplied historical company material |
| Unified social credit code | 91140000602311789X | Entity identifier recorded in the official archive |
| Manufacturing-licence reference | 晋20160034 | A reference number; not a blanket certification of the shop |
| Historical licence dates | Issued 5 September 2023; recorded expiry 20 December 2025 | The archive is historical, not evidence of today’s validity |
View the official historical archive ↗
Current-document status. A commercial database reports a licence issued on 14 August 2026 with validity to 10 December 2030. That is a secondary-source record. The current original licence and annex have not yet been verified for this presentation. The historical expiry above must not be interpreted as a finding that the company’s current licence has expired.
View the secondary licence listing ↗
Published biological-product release records
The following are selected examples, not an annual production total. The documents identify Kangbao in the marketing authorisation holder field and apply only to the listed products and lots. They do not identify the origin or testing of a research-catalog peptide.
| Published period | Selected named lots | Institution |
|---|---|---|
| 7–13 June 2026 | Factor VIII YZ20260309; fibrinogen XY20260302; prothrombin complex MY20260303; albumin RB20260308 | Beijing Institute for Drug Control, as recorded in the official release portal |
| 6–12 September 2026 | Examples include factor VIII YZ20260615 and albumin RB20260522; the linked source contains the complete period’s entries | Beijing Institute for Drug Control, as recorded in the official release portal |
Open the institution’s official release-record index ↗ — select the dated periods above to inspect the product names, lot numbers, certificate references and conclusions.
Batch-release administration covers the product categories specified by the applicable rules. It is not a rule that every sterile biological product or every research peptide undergoes the same national release process. Some covered products can be assessed through document review or a combination of review and testing; a release entry should not be rewritten as a claim of every possible independent laboratory test.
Read the official batch-release rules, including Articles 2 and 19 ↗
Documents for research-catalog materials
For a purchase from the research shop, check the product identity, lot, issuing party, method and reported result in the actual available documentation. A company registration, a patent, or an albumin release record cannot substitute for an analytical report for a different material.
Read the product-document guide ↗ Look up an available certificate →
Website and cooperation context
HealthyWelness independently operates the website, research shop, orders and support. Company materials are being presented in connection with a proposed overseas cooperation with Kangbao. Supply, distribution and manufacturing arrangements remain project-specific. No parent-company, subsidiary or blanket product-manufacturer relationship is claimed.
Images, permissions and updates
Corporate archive imagery is identified as such. It is not a current inspection record or a photograph proving the production of a listed research material. Current company confirmation should cover the photograph’s identity, date and allowed publication use, as well as the final corporate wording.
Contact HealthyWelness about a discrepancy, an updated document or an enquiry. Corrected source information should retain its issue date and its relationship to the material it actually covers.
Information reviewed against the cited sources on 15 November 2026. A published record applies to the named entity, product and date; it is not a general certification of the research catalog.